Metastatic Urethral Urothelial Carcinoma Recruiting Phase 1 Trials for Platinum (DB12257)

Indication	Status	Phase
DBCOND0110111 (Metastatic Urethral Urothelial Carcinoma)	Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03582475	Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate	Treatment	Beta-D-Glucose (DB02379) Carbocisteine (DB04339) Carboplatin (DB00958) Chloride ion (DB14547) Cisplatin (DB00515) Docetaxel (DB01248) Etoposide (DB00773) Pembrolizumab (DB09037) Platinum (DB12257)